Metabolic profiling of four synthetic stimulants, including the novel indanyl-cathinone 5-PPDi, after human hepatocyte incubation by David Fabregat-Safont, Marie Mardal, Juan V. Sancho, Félix Hernández, Kristian Linnet, María Ibáñez

Get full text

PRECLINICAL EFFICACY OF A NEWLY IDENTIFIED COMPOUND IN DEPRESSIVE-LIKE PHENOTYPES IN MICE by Carla Ramon-Duaso, Jose Rodríguez-Morató, Àlex Gómez-Gómez, David Fabregat-Safont, Óscar Pozo, Arnau Busquets Garcia

Get full text

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans by Francisco Madrid-Gambin, David Fabregat-Safont, Alex Gomez-Gomez, Eulàlia Olesti, Natasha L. Mason, Johannes G. Ramaekers, Oscar J. Pozo

Get full text

Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models by Luis Filipe Costa-Machado, Esther Garcia-Dominguez, Rebecca L. McIntyre, Jose Luis Lopez-Aceituno, Álvaro Ballesteros-Gonzalez, Andrea Tapia-Gonzalez, David Fabregat-Safont, Tobias Eisenberg, Jesús Gomez, Adrian Plaza, Aranzazu Sierra-Ramirez, Manuel Perez, David Villanueva-Bermejo, Tiziana Fornari, María Isabel Loza, Gonzalo Herradon, Sebastian J. Hofer, Christoph Magnes, Frank Madeo, Janet S. Duerr, Oscar J. Pozo, Maximo-Ibo Galindo, Isabel del Pino, Riekelt H. Houtkooper, Diego Megias, Jose Viña, Mari Carmen Gomez-Cabrera, Pablo J. Fernandez-Marcos

Get full text